VITEX Appoints New Member to Board of Directors

Article

WATERTOWN, Mass--VI Technologies (VITEX) has announced the appointment of Joseph M. Limber to its Board of Directors.

Limber, currently the president and CEO of ACLARA BioSciences, Inc., has 25 years of biotechnology and pharmaceutical management experience.

VITEX is a biotechnology company responsible for developing products that inactive and remove pathogens in blood. Using nucleic acid chemistry, the company produced Inactine Pathogen Inactivation. The technology inactivates blood-borne viruses and bacteria and is in Phase II of clinical trials.

Recent Videos
Cameron Memorial Community Hospital Series With ICT
Ambassador Deborah L. Birx, MD, senior fellow of the George W. Bush Presidential Center
Cameron Memorial Community Hospital series with ICT (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT (Image Credit: CMCH)
Cameron Memorial Community Hospital series with ICT (Image Credit: CMCH)
Isis Lamphier, MPH, MHA, CIC; Tori Whitacre Martonicz, MA; and Heather Stoltzfus, MPH, RN, CIC, at APIC Conference and Expo 2024 (Photo courtesy of Tori Whitacre Martonicz)
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
• Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Related Content
The Association for Professionals in Infection Control & Epidemiology (APIC) (Image courtesy of APIC)

Gag Order Puts Public Health at Risk, APIC Urges Immediate Action

Infection Control Today® Editorial Staff
February 4th 2025
Article

APIC warns that the HHS gag order on CDC communications endangers public health, delaying critical infection updates and weakening outbreak response amid rising tuberculosis, avian flu, Ebola, and measles threats.

Infection Control Today's Bug of the Month

Bug of the Month: A Quiet Invader

Heather Stoltzfus, MPH, RN, CIC
February 4th 2025
Article

The Bug of the Month helps educate readers about existing and emerging pathogens that are clinically important in today's health care facilities.

Washington, DC - April 3, 2023: US Agency for International Development office entrance sign (Adobe Stock 589286072 by John Hanson Pye)

USAID in Crisis: A Global Catastrophe Unfolding

Heather Stoltzfus, MPH, RN, CIC
February 3rd 2025
Article

The sudden suspension of USAID funding is triggering a worldwide humanitarian emergency, threatening health systems, economic stability, and global security—undoing decades of progress in development and disease control.

Human metapneumovirus HMPV molecular closeup in 3d rendering with hospital setting. (Adobe Stock 1173397419 by Loki Studio)

What Is hMPV, and Could It Be the Next Pandemic?

Pallavi Upadhyay, PhD
February 3rd 2025
Article

A surge in human metapneumovirus (hMPV) cases highlights the need for improved detection, prevention, and public awareness, particularly for vulnerable populations such as children, elderly, and immunocompromised individuals.

HIV/AIDS (Adobe Stock unknown)

Breaking Barriers: The Future of HIV Prevention and the Fight for Widespread PrEP Access

Zeena Nackerdien, PhD
January 31st 2025
Article

Despite medical advances, HIV prevention faces roadblocks—low PrEP adoption, stigma, and accessibility issues threaten progress. Experts push for innovative, long-acting solutions to end the epidemic.

Hospital Ventilation (Adobe Stock 478081049 by mjowra)

The Hidden Dangers of Hospital Ventilation: Are We Spreading Viruses Further?

Tori Whitacre Martonicz
January 31st 2025
Article

New research reveals hospital ventilation and air purifiers may unintentionally spread viral particles, increasing infection risks. Infection preventionists must rethink airflow strategies to protect patients and staff.